| 摘要 |
<p>A prodrug represented by the Formula (I): A - X - B, wherein A comprises a carrier that selectively effects release of B at hypoxic sites in the brain; X comprises a cleavable linker; and B comprises at least one active moiety of a therapeutic agent for the treatment of stroke or other ischaemic conditions.</p> |
